BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2021 5:24:00 AM | Browse: 331 | Download: 515
 |
Received |
|
2021-03-01 22:23 |
|
Peer-Review Started |
|
2021-03-01 22:30 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-06 02:57 |
|
Revised |
|
2021-07-16 07:56 |
|
Second Decision |
|
2021-11-11 03:17 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-11-15 03:11 |
|
Articles in Press |
|
2021-11-15 03:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-21 04:06 |
|
Publish the Manuscript Online |
|
2021-12-27 05:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago and Roberto Grassia |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Stefano Mazza, MD, Doctor, Gastroenterology and Digestive Endoscopy Unit, ASST Cremona, Viale Concordia 1, Cremona 26100, Italy. stem311089@gmail.com |
| Key Words |
Inflammatory bowel diseases; Hepatobiliary disorders; Primary sclerosing cholangitis; Drug-induced liver injury; Biological drugs; Viral hepatitis |
| Core Tip |
Hepatobiliary disorders are commonly associated with inflammatory bowel diseases (IBD) and represent a management challenge. They include (1) Immune-mediated diseases that can coexist with IBD, mainly primary sclerosing cholangitis; (2) Other non-immune-mediated disorders like gallstone disease; (3) Liver injury induced by drugs used in IBD; and (4) Risks related to concomitant viral hepatitis B and C. All these conditions are summarized in this review, according to the latest literature evidence and the current clinical practice guidelines. |
| Publish Date |
2021-12-27 05:24 |
| Citation |
Mazza S, Soro S, Verga MC, Elvo B, Ferretti F, Cereatti F, Drago A, Grassia R. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World J Hepatol 2021; 13(12): 1828-1849 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i12/1828.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i12.1828 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
